by admin_prosemble | 30th January 2026 | News
Prosemble has received results from ongoing test of its protein nanoparticles in CD34+ humanised NCG mice. The results indicate excellent immunogenicity, with no B-cell activation, minimal cytokine production, and T-cell activation only due to natural ageing. Next...
by admin_prosemble | 22nd January 2026 | News
On 22 January 2026, Inna Zhuranskaya participated in the Women-Led Global Business Programme in Health-Tech, organized by the Biotechnology Industry Research Assistance Council (BIRAC) in collaboration with UKRI India and Innovate UK. The delegation’s visit to Chennai...
by admin_prosemble | 21st January 2026 | News
On 21 January 2026, Inna Zhuranskaya participated in the UK Research and Innovation (UKRI) & Innovate UK Global Business Innovation Programme (GBIP) – Women in Innovation Health-Tech, hosted in Bengaluru. The delegation, featuring 12 women-led companies from the...
by admin_prosemble | 20th January 2026 | News
On 19 January 2026, Inna Zhuranskaya participated in the UK Women-Led Startup Cohort event hosted by UKRI India, alongside Innovate UK and IKP Knowledge Park. During the event, she shared valuable insights on navigating healthcare systems across borders, a critical...
by admin_prosemble | 19th January 2026 | News
Inna Zhuranskaya and Prosemble would like to extend their heartfelt thanks to Dilruk Yahathugoda for his invaluable support during the Innovate UK Global Business Innovation Programme (GBIP) – Healthcare Women in Innovation in Bengaluru. This initiative has provided a...
by admin_prosemble | 14th January 2026 | News
On 14 January 2026, Judy Kingswolf-Yamakawa presented at The Cancer Tech Accelerator (CTA) Conference 2026, held at the London Institute for Healthcare Engineering (LIHE). The event brought together innovators, investors, researchers, and industry partners to explore...
